Med Tech Talks Podcast

Bionics Institute
  • 5.0 (2)
  • Life Sciences

Robert Klupacs, CEO of the Bionics Institute, a world leader in medical device development, talks to leaders, investors, researchers and entrepreneurs in the med tech industry. He delves into their story, who and what motivated them along the way, and their advice to those following a similar path. He also explores the concept of innovation, and what it will take to improve the translation of innovation into commercialisation to change the lives of people living with challenging medical conditions.

  1. 2d ago

    The past, present and future of cochlear implants with Cochlear CTO Jan Janssen

    In this episode of Med Tech Talks, Bionics Institute CEO Robert Klupacs is joined by Jan Janssen, Chief Technology Officer of Cochlear Ltd, the global leader in implantable hearing solutions.  Jan has spent more than three decades at the forefront of medical technology innovation, helping shape the development of the world's most advanced cochlear implant systems. As Cochlear's Chief Technology Officer, he leads the company's global research and development strategy, overseeing multidisciplinary teams that are pushing the boundaries of hearing technology, digital health, and implantable medical devices.  Throughout his career, Jan has played a pivotal role in translating breakthrough engineering and scientific research into technologies that have transformed the lives of hundreds of thousands of people living with hearing loss. His work spans implant design, sound processing, connectivity, and the next generation of smart hearing solutions, ensuring Cochlear remains at the forefront of innovation in hearing healthcare.  What makes Jan's story particularly compelling is his commitment to building on the extraordinary legacy established by Professor Graeme Clark, a shared founder of Cochlear and the Bionics Institute. Under his technical leadership, Cochlear continues to advance that legacy—bringing together engineering, clinical science, and digital technologies to improve hearing outcomes for people around the world.  Today's conversation is an opportunity to explore not only where cochlear implant technology has come from, but where it's heading next—from artificial intelligence and personalised hearing solutions to the future of connected healthcare and global innovation.  Updated version 05/08/22

  2. Jul 3

    From Apple & Canva to Cochlear Implants: Guy Kawasaki on innovation that changes lives

    Calling in from the United States, Guy is widely regarded as the pioneer of modern evangelism in the technology industry, having played a pivotal role in building a passionate developer and user community around the Macintosh during its formative years.  At a time when personal computing was still in its infancy, Guy helped translate complex technology into something accessible, inspiring, and deeply human. Since his time at Apple, Guy has become a globally respected voice on innovation, entrepreneurship, and the art of storytelling – something we are passionate about at the Bionics Institute.  As an author, speaker, and venture capitalist, he has worked with countless startups and leaders, helping them to refine their vision, communicate their ideas, and bring transformative products to market. He also has a very successful podcast, Guy Kawasaki’s Remarkable People Podcast, which I recommend all our listeners should view after this podcast. Guy's latest book is called Everybody Has Something to Hide, and it will help you strengthen your privacy and security. What sets Guy apart is his unique ability to bridge technology and impact—championing not just great products, but the ideas and values that make a difference in people’s lives.   Updated version 05/08/22

  3. Jun 3

    Revolutionising Paediatric Healthcare with Navi Technologies CEO Alex Newton

    Navi Medical is an Australian medtech company with a very clear and compelling mission: to improve outcomes for some of the most vulnerable patients in our healthcare system—critically ill newborns and children. The company was founded on a simple but striking reality: many of the devices used in neonatal and paediatric care today are not designed for children at all, but adapted from adult medicine.  In response, Navi has focused its efforts on developing purpose-built technologies for paediatric care, working closely with clinicians in neonatal and paediatric intensive care units to understand real-world challenges and design solutions that genuinely improve safety and outcomes. Navi’s latest development is the Neonav device – an ECG tip-location system that improves umbilical monitoring for the most fragile neonatal patients. It achieved FDA registration in 2025. As CEO, Alex has led Navi from its early beginnings in Melbourne through to clinical development and commercialisation, building a multidisciplinary team spanning engineering, clinical care and business, all united by a shared goal: delivering brighter, healthier futures for children.  Updated version 05/08/22

  4. Apr 24

    Supporting the Australian Innovation Ecosystem with Dr Andrew Nash

    In this latest episode of Med Tech Talks, Robert Klupacs is joined by Dr Andrew Nash, former CSO of CSL.  CSL is an Australian success story and one of the world’s leading biotechnology companies. CSL has a remarkable history spanning over a century, and a global reputation for developing and delivering life-saving medicines, particularly in immunology, haematology, and vaccines. As Chief Scientific Officer, Andrew led CSL’s global research and early development strategy, playing a pivotal role in advancing innovative therapies from discovery through to clinical development, and ultimately to patients around the world. Today, Andrew is a Director of: The Garvan Institute of Medical Research, the Burnet Institute, ASX listed Arovella, Jumar Incubator, Brandon Capital’s BioCatalyst and also part of the Bionics Institute’s own Industry Advisory Committee.  In this episode, you will learn from Andrew about: Andrew's journey from academia to CSO of CSLHis thoughts on the opportunity for innovation in AustraliaWhat Andrew would recommend to aspiring med tech and bio tech enterpreneurs to be successfulLearn more about Dr Andrew Nash Learn more about CSL Updated version 05/08/22

  5. 03/28/2025

    Inside The Eye and Ear Hospital with CEO Brendon Gardner

    In this latest episode of Med Tech Talks, Robert Klupacs is joined by Brendon Gardner, CEO of The Royal Victorian Eye and Ear Hospital (Eye and Ear) in Melbourne. The Royal Victorian Eye and Ear Hospital is Australia’s only specialist eye, ear, nose and throat hospital and has been operating since 1863. The Eye and Ear sees over 250,000 patients a year and offers over 110 different outpatient clinics for the diagnosis, monitoring and treatment of vision and hearing loss. The hospital also has...

  6. 02/06/2025

    Insights on Commercialisation, Spinouts, and Entrepreneurship with Dr Alastair Hick

    In this episode of Med Tech Talks, Robert Klupacs is joined by Dr Alastair Hick, Chief Commercialisation Officer at Monash University. With a PhD in Chemical Ecology and an MBA from the Judge Business School at the University of Cambridge, Alastair has a wealth of experience both in Australian and overseas markets and brings an ecosystem approach to commercialisation and innovation. At Monash University, Alastair has been responsible has developed a successful IP commercialisation program and...

  7. 12/12/2024

    Revolutionising Stroke Diagnosis: Scott Kirkland on EMVision's Portable Brain Scanner

    In this episode of Med Tech Talks, Robert Klupacs is joined by Scott Kirkland, CEO and Managing Director of EMVision Medical Devices. EMVision (ASX:EMV) is an ASX listed, Australian med tech company focused on developing portable brain imaging devices using electromagnetic (EM) technology. It was spun out of University of Queensland in 2017 and had its IPO in late-2018. EMVision’s primary product is a portable scanner designed to quickly and non-invasively detect and monitor neuro...

  8. 11/01/2024

    Beyond Opioids: Justin Zenanko’s Vision for Spinal Fusion and Chronic Pain Relief

    In this episode of Med Tech Talks, Robert Klupacs is joined by Justin Zenanko, co-founder, CEO and president of SynerFuse™, a medical device company based in the United States developing an innovative solution to reduce chronic back pain and improve patient quality of life. Justin and his team have patented the SynerFuse e-TLIF™ procedure which aims to make traditional spine implant surgery more successful and cost effective by combining neuromodulation at the time surgeons are perform...

See All (45)

Ratings & Reviews

5
out of 5
2 Ratings

About

Robert Klupacs, CEO of the Bionics Institute, a world leader in medical device development, talks to leaders, investors, researchers and entrepreneurs in the med tech industry. He delves into their story, who and what motivated them along the way, and their advice to those following a similar path. He also explores the concept of innovation, and what it will take to improve the translation of innovation into commercialisation to change the lives of people living with challenging medical conditions.

Information

  • Creator
    Bionics Institute
  • Years Active
    2022 - 2026
  • Episodes
    45
  • Rating
    Explicit
  • Copyright
    © 2026 Bionics Institute Med Tech Talks Podcast
  • Show Website
    Med Tech Talks Podcast